M

Midwest Cardiovascular Research and Education Foundation | Elkhart, IN

Research site

(Unclaimed)

Location

500 Arcade Avenue, Suite 400, Elkhart, Indiana, United States of America

Site insights

Top conditions

Top treatments

Empagliflozin

Aspirin

Plozasiran

Finerenone

Obicetrapib

Prasugrel

EMPagliflozin

lisinopril

Evolocumab

losartan

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 13 total trials

Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease (PREVAIL)

This study will be a placebo-controlled, double-blind, randomized, phase 3 study in participants with Atherosclerotic Cardiovascular Disease (ASCVD)...

Active, not recruiting

Atherosclerotic Cardiovascular Disease

Drug: Obicetrapib

Drug: Placebo

Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia (MUIR-3)

This Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with hypertriglyceridemia (HTG). A...

Enrolling

Hypertriglyceridemia

Drug: Placebo

Drug: Plozasiran Injection

Study of Plozasiran in Adults With Severe Hypertriglyceridemia (SHASTA-4)

This Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with severe hypertriglyceridemia (...

Enrolling

Severe Hypertriglyceridemia

Drug: Placebo

Drug: Plozasiran Injection